Repligen Corp (RGEN)
142.58
+0.82
(+0.58%)
USD |
NASDAQ |
Nov 22, 16:00
142.62
+0.04
(+0.03%)
After-Hours: 20:00
Repligen Cash from Operations (Quarterly): 49.32M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 49.32M |
| June 30, 2024 | 42.19M |
| March 31, 2024 | 44.71M |
| December 31, 2023 | 29.06M |
| September 30, 2023 | 39.23M |
| June 30, 2023 | 34.47M |
| March 31, 2023 | 11.15M |
| December 31, 2022 | 61.88M |
| September 30, 2022 | 41.37M |
| June 30, 2022 | 45.72M |
| March 31, 2022 | 23.11M |
| December 31, 2021 | 49.62M |
| September 30, 2021 | 22.48M |
| June 30, 2021 | 37.65M |
| March 31, 2021 | 9.262M |
| December 31, 2020 | 14.87M |
| September 30, 2020 | 21.49M |
| June 30, 2020 | 16.74M |
| March 31, 2020 | 9.53M |
| December 31, 2019 | 17.67M |
| September 30, 2019 | 21.96M |
| June 30, 2019 | 17.79M |
| March 31, 2019 | 9.788M |
| December 31, 2018 | 5.555M |
| September 30, 2018 | 19.68M |
| Date | Value |
|---|---|
| June 30, 2018 | 5.963M |
| March 31, 2018 | 1.572M |
| December 31, 2017 | 15.22M |
| September 30, 2017 | -1.728M |
| June 30, 2017 | 2.814M |
| March 31, 2017 | 1.147M |
| December 31, 2016 | 1.954M |
| September 30, 2016 | -1.186M |
| June 30, 2016 | 10.56M |
| March 31, 2016 | -3.811M |
| December 31, 2015 | 3.352M |
| September 30, 2015 | 6.588M |
| June 30, 2015 | 7.418M |
| March 31, 2015 | -2.305M |
| December 31, 2014 | 1.753M |
| September 30, 2014 | 6.328M |
| June 30, 2014 | 2.322M |
| March 31, 2014 | 7.999M |
| December 31, 2013 | 6.962M |
| September 30, 2013 | 6.577M |
| June 30, 2013 | 8.796M |
| March 31, 2013 | 3.595M |
| December 31, 2012 | 7.229M |
| September 30, 2012 | 2.471M |
| June 30, 2012 | 2.005M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
9.262M
Minimum
Mar 2021
61.88M
Maximum
Dec 2022
31.08M
Average
31.77M
Median
Cash from Operations (Quarterly) Benchmarks
| West Pharmaceutical Services Inc | 180.10M |
| QuidelOrtho Corp | 117.90M |
| Perspective Therapeutics Inc | 3.366M |
| Xtant Medical Holdings Inc | -1.718M |
| Catheter Precision Inc | -2.768M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -5.859M |
| Cash from Financing (Quarterly) | -69.60M |
| Free Cash Flow | 131.26M |
| Free Cash Flow Per Share (Quarterly) | 0.7531 |
| Free Cash Flow to Equity (Quarterly) | 107.78M |
| Free Cash Flow to Firm (Quarterly) | 45.34M |
| Free Cash Flow Yield | 1.64% |